Related references
Note: Only part of the references are listed.Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness
Julia Ramirez-Moya et al.
ONCOGENE (2019)
ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation
Xue Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
miRNA-Directed Regulation of the Main Signaling Pathways in Thyroid Cancer
Julia Ramirez-Moya et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Jeffrey J. Ishizuka et al.
NATURE (2019)
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
Huayang Liu et al.
NATURE MEDICINE (2019)
MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN
Julia Ramirez-Moya et al.
ONCOGENE (2018)
ADARs and editing: The role of A-to-I RNA modification in cancer progression
Kajsa Fritzell et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells
Hugh S. Gannon et al.
NATURE COMMUNICATIONS (2018)
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers
Yumeng Wang et al.
GENOME RESEARCH (2017)
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Hyeyeun Lim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Key signaling pathways in thyroid cancer
Miguel A. Zaballos et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs
Carl R. Walkley et al.
GENOME BIOLOGY (2017)
A-to-I editing of coding and non-coding RNAs by ADARs
Kazuko Nishikura
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis
Maria Anna Zipeto et al.
CELL STEM CELL (2016)
β-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation
Ana Sastre-Perona et al.
ONCOTARGET (2016)
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
Leng Han et al.
CANCER CELL (2015)
The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells during Carcinogenesis
Garcilaso Riesco-Eizaguirre et al.
CANCER RESEARCH (2015)
ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
Peijing Zhang et al.
CELL CYCLE (2015)
Three-Dimensional Cell Culture: A Breakthrough in Vivo
Delphine Antoni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
An RNA editing fingerprint of cancer stem cell reprogramming
Leslie A. Crews et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis
Einav Shoshan et al.
NATURE CELL BIOLOGY (2015)
Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors
Nurit Paz-Yaacov et al.
CELL REPORTS (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
MiR-200, a new star miRNA in human cancer
Xiangling Feng et al.
CANCER LETTERS (2014)
Adenosine-to-Inosine RNA Editing Mediated by ADARs in Esophageal Squamous Cell Carcinoma
Yan-Ru Qin et al.
CANCER RESEARCH (2014)
RNA Editome Imbalance in Hepatocellular Carcinoma
Lihua Qi et al.
CANCER RESEARCH (2014)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Deregulation of microRNA expression in thyroid neoplasias
Pierlorenzo Pallante et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
The Role of Epithelial Mesenchymal Transition Markers in Thyroid Carcinoma Progression
Celina Montemayor-Garcia et al.
ENDOCRINE PATHOLOGY (2013)
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth
Yael Nemlich et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma
Jiaxing Zhang et al.
MOLECULAR BIOLOGY REPORTS (2013)
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia
Qingfei Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
Review of MiR-200b and cancer chemosensitivity
Bing Feng et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma
Aidong Shen et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma
Baoqing Jia et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas
J. Braun et al.
ONCOGENE (2010)
ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
E. Sanchez-Tillo et al.
ONCOGENE (2010)
Large-scale mRNA sequencing determines global regulation of RNA editing during brain development
Helene Wahlstedt et al.
GENOME RESEARCH (2009)
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition
Cameron P. Bracken et al.
CANCER RESEARCH (2008)
MicroRNAs as regulators of epithelial-mesenchymal transition
Philip. A. Gregory et al.
CELL CYCLE (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
Emily L. Paterson et al.
THESCIENTIFICWORLDJOURNAL (2008)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
p150 ADAR1 isoform involved in maintenance of HeLa cell proliferation
Haifang Wang et al.
BMC CANCER (2006)
Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells
N Mitsutake et al.
CANCER RESEARCH (2005)
The many roles of an RNA editor
LP Keegan et al.
NATURE REVIEWS GENETICS (2001)
Share Paper
